Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Scaffolds | 4 | 2022 | 199 | 2.370 |
Why?
|
| Tissue Engineering | 5 | 2022 | 392 | 2.170 |
Why?
|
| Fibroblasts | 3 | 2020 | 939 | 1.050 |
Why?
|
| Ankle Brachial Index | 1 | 2024 | 37 | 0.890 |
Why?
|
| Bioreactors | 3 | 2020 | 43 | 0.890 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2020 | 124 | 0.860 |
Why?
|
| Intermittent Claudication | 1 | 2024 | 118 | 0.820 |
Why?
|
| Ischemia | 2 | 2024 | 395 | 0.820 |
Why?
|
| Veterans Health | 1 | 2024 | 175 | 0.790 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2022 | 104 | 0.730 |
Why?
|
| Vascular Surgical Procedures | 1 | 2024 | 294 | 0.720 |
Why?
|
| Polyethylene Glycols | 3 | 2022 | 597 | 0.700 |
Why?
|
| Endovascular Procedures | 2 | 2024 | 304 | 0.680 |
Why?
|
| Biocompatible Materials | 2 | 2020 | 398 | 0.650 |
Why?
|
| Biodegradable Plastics | 1 | 2019 | 3 | 0.650 |
Why?
|
| Frailty | 1 | 2022 | 153 | 0.640 |
Why?
|
| Peripheral Arterial Disease | 2 | 2024 | 458 | 0.580 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 275 | 0.570 |
Why?
|
| Materials Testing | 1 | 2019 | 346 | 0.560 |
Why?
|
| Surgeons | 1 | 2021 | 277 | 0.560 |
Why?
|
| Lower Extremity | 4 | 2022 | 404 | 0.540 |
Why?
|
| Porosity | 3 | 2022 | 94 | 0.520 |
Why?
|
| Polyglycolic Acid | 3 | 2020 | 42 | 0.510 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2020 | 245 | 0.480 |
Why?
|
| Arteries | 2 | 2014 | 267 | 0.420 |
Why?
|
| Risk Assessment | 4 | 2024 | 3260 | 0.410 |
Why?
|
| Aorta, Abdominal | 1 | 2011 | 42 | 0.380 |
Why?
|
| Regenerative Medicine | 1 | 2011 | 46 | 0.360 |
Why?
|
| Extracellular Matrix | 3 | 2022 | 498 | 0.340 |
Why?
|
| Veterans | 1 | 2021 | 1419 | 0.340 |
Why?
|
| Stress, Mechanical | 3 | 2020 | 465 | 0.330 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2011 | 199 | 0.320 |
Why?
|
| Risk Factors | 5 | 2024 | 9769 | 0.310 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2011 | 417 | 0.310 |
Why?
|
| Postoperative Complications | 3 | 2022 | 2496 | 0.260 |
Why?
|
| Retrospective Studies | 4 | 2024 | 14571 | 0.240 |
Why?
|
| Treatment Outcome | 4 | 2024 | 10227 | 0.230 |
Why?
|
| Limb Salvage | 1 | 2024 | 58 | 0.220 |
Why?
|
| Pressure | 3 | 2020 | 240 | 0.200 |
Why?
|
| Frail Elderly | 1 | 2022 | 121 | 0.180 |
Why?
|
| Time Factors | 4 | 2024 | 6518 | 0.170 |
Why?
|
| Biomimetics | 1 | 2020 | 40 | 0.170 |
Why?
|
| Tensile Strength | 1 | 2020 | 97 | 0.170 |
Why?
|
| Elastic Modulus | 1 | 2020 | 123 | 0.170 |
Why?
|
| Cross-Linking Reagents | 1 | 2020 | 206 | 0.160 |
Why?
|
| Humans | 12 | 2024 | 129128 | 0.150 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 1943 | 0.150 |
Why?
|
| Collagen | 1 | 2020 | 429 | 0.150 |
Why?
|
| Extremities | 1 | 2017 | 128 | 0.130 |
Why?
|
| Disease Progression | 1 | 2024 | 2613 | 0.130 |
Why?
|
| Pain | 1 | 2021 | 760 | 0.130 |
Why?
|
| Skin | 1 | 2020 | 719 | 0.120 |
Why?
|
| Aged | 3 | 2024 | 22090 | 0.120 |
Why?
|
| Shear Strength | 1 | 2014 | 67 | 0.110 |
Why?
|
| Saphenous Vein | 1 | 2014 | 32 | 0.110 |
Why?
|
| Receptor, EphB4 | 1 | 2014 | 36 | 0.110 |
Why?
|
| Cell Line | 1 | 2019 | 2737 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 7066 | 0.100 |
Why?
|
| Hypertonic Solutions | 1 | 2011 | 7 | 0.100 |
Why?
|
| Rats, Nude | 1 | 2011 | 27 | 0.100 |
Why?
|
| Hydrostatic Pressure | 1 | 2011 | 18 | 0.100 |
Why?
|
| Length of Stay | 1 | 2017 | 1124 | 0.100 |
Why?
|
| Patient Readmission | 1 | 2017 | 668 | 0.100 |
Why?
|
| Detergents | 1 | 2011 | 45 | 0.090 |
Why?
|
| Vascular Patency | 1 | 2011 | 102 | 0.090 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 84 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 142 | 0.090 |
Why?
|
| Suture Techniques | 1 | 2011 | 121 | 0.090 |
Why?
|
| Prosthesis Failure | 1 | 2011 | 120 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 141 | 0.090 |
Why?
|
| Perfusion | 1 | 2011 | 188 | 0.090 |
Why?
|
| Sirolimus | 1 | 2011 | 189 | 0.080 |
Why?
|
| Endothelial Cells | 2 | 2014 | 701 | 0.080 |
Why?
|
| Carotid Arteries | 1 | 2011 | 207 | 0.080 |
Why?
|
| Blood Coagulation | 1 | 2011 | 226 | 0.080 |
Why?
|
| Swine | 1 | 2011 | 745 | 0.080 |
Why?
|
| Biomechanical Phenomena | 1 | 2011 | 780 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2011 | 724 | 0.070 |
Why?
|
| Stem Cells | 1 | 2011 | 579 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2011 | 4010 | 0.060 |
Why?
|
| United States | 1 | 2021 | 13940 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2011 | 2347 | 0.050 |
Why?
|
| Female | 3 | 2024 | 68518 | 0.050 |
Why?
|
| Rats | 1 | 2011 | 5173 | 0.050 |
Why?
|
| Blood Circulation | 1 | 2002 | 40 | 0.050 |
Why?
|
| Middle Aged | 1 | 2024 | 31080 | 0.050 |
Why?
|
| Pyranocoumarins | 1 | 2002 | 1 | 0.050 |
Why?
|
| Measles virus | 1 | 2002 | 13 | 0.050 |
Why?
|
| Coumarins | 1 | 2002 | 21 | 0.050 |
Why?
|
| Models, Cardiovascular | 1 | 2002 | 190 | 0.050 |
Why?
|
| Vascular Resistance | 1 | 2002 | 369 | 0.050 |
Why?
|
| Animals | 3 | 2011 | 34600 | 0.040 |
Why?
|
| Male | 2 | 2024 | 63202 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2011 | 4838 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2002 | 706 | 0.030 |
Why?
|
| Tissue Survival | 1 | 2014 | 16 | 0.030 |
Why?
|
| Hemorheology | 1 | 2014 | 21 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 374 | 0.030 |
Why?
|
| Models, Biological | 1 | 2014 | 1695 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 2438 | 0.020 |
Why?
|
| Rheology | 1 | 2002 | 90 | 0.010 |
Why?
|
| Neutral Red | 1 | 2002 | 1 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2002 | 14 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2002 | 81 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2002 | 76 | 0.010 |
Why?
|
| Virion | 1 | 2002 | 85 | 0.010 |
Why?
|
| Ribavirin | 1 | 2002 | 92 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2002 | 358 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 531 | 0.010 |
Why?
|
| Virus Replication | 1 | 2002 | 444 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2002 | 1084 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 35513 | 0.010 |
Why?
|